肾细胞癌多期增强CT上集合系统侵犯的患病率、特征及临床意义
该回顾性研究纳入2008年1月至2017年12月病理确诊为肾细胞癌的340例患者共347个肾脏,按多期CT有无集合系统侵犯(CSI)分组,比较临床特征、影像表现及总生存(OS)和无复发生存(RFS)。CT上CSI患病率为3%(95%CI 1.3-5.0%),以病理CSI为参考标准,CT诊断CSI的敏感度50%、特异度99.7%、准确率97.1%,两组OS和RFS无显著差异。
要点
- 多期CT上肾细胞癌集合系统侵犯患病率低,为3%(95%CI 1.3-5.0%)。
- 以病理为参考,CT诊断CSI敏感度50%、特异度99.7%、准确率97.1%。
- CT有CSI与无CSI患者的总生存和无复发生存率无显著差异。
关键影像表现/征象
- 11个肾脏在多期CT上观察到集合系统侵犯,病理均诊断为透明细胞型肾细胞癌,其中1个肾脏肿瘤还伴有肉瘤样特征。
- CT上集合系统侵犯表现为肿瘤侵犯集合系统,原文未进一步描述具体影像征象。
诊断标准与关键数值
- 以病理集合系统侵犯为参考标准,CT诊断集合系统侵犯的敏感度为50%、特异度为99.7%、准确率为97.1%。
- 多期CT上肾细胞癌集合系统侵犯的患病率为3%(95%置信区间1.3-5.0%)。
临床应用与阅片要点
- 阅片时应注意评估肾细胞癌是否侵犯集合系统,但CT诊断敏感度仅50%,阴性不能排除病理集合系统侵犯。
- CT上集合系统侵犯与OS和RFS无显著差异,原文未据此给出推荐。
局限性
- 因患病率低,不能排除CT上CSI与OS和RFS相关的可能性。
- 需进一步研究确定CT上CSI能否作为肾细胞癌患者生存的独立预后因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to determine the prevalence of collecting system invasion (CSI) on multiphasic CT, validate the pathological findings, and investigate the relationship between CSI and clinical outcomes in patients with renal cell carcinomas (RCC).
METHODS: Patients pathologically diagnosed with RCC between January 2008 and December 2017 were retrospectively enrolled in this study. They were divided into two groups according to the presence of CSI on multiphasic CT images. Patients' clinical characteristics, radiological findings, and overall survival (OS) and recurrence-free survival (RFS) rates were analyzed and compared between the groups. In addition, the correlation of radiological findings with pathological findings was investigated.
RESULTS: Among the included 347 kidneys of 340 patients, CSI was observed in 11 kidneys (3%; 95% confidence interval, 1.3-5.0%). In all the 11 kidneys, the tumors were pathologically diagnosed as clear cell RCC, and in one kidney, the tumor also had sarcomatoid features. When pathological CSI served as the standard of reference, the sensitivity, specificity, and accuracy of CSI on CT were 50%, 99.7%, and 97.1%, respectively. The OS and RFS rates were not significantly different between patients with CSI on CT and those without CSI.
CONCLUSION: This study found that the prevalence of RCC-related CSI was 3%. Because of the low prevalence, we cannot exclude the possibility that CSI on CT would be associated with the OS and RFS. Further studies are needed to determine whether CSI on CT can be an independent prognostic factor for survival in patients with RCC.
引用
- Takamatsu A, Yoshida K, Obokata M, et al. Urinary collecting system invasion on multiphasic CT in renal cell carcinomas: prevalence, characteristics, and clinical significance. Abdom Radiol (NY). 2020. PMID: 33226457. doi:10.1007/s00261-020-02859-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。